🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VRT
$VRTX
🔒 US EquitiesVertex Pharmaceuticals Incorpor
AVG HISTORICAL GAP
-1.93%
MAX GAP RECORD
-13.56%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VRTX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VRTX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 03, 2026 Earnings Release 2026-08-03 (AFTER CLOSE) |
+0.12%
|
| May 04, 2026 Earnings Release 2026-05-04 (AFTER CLOSE) |
+0.50%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (AFTER CLOSE) |
+1.43%
|
| Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE) |
-1.75%
|
| Aug 04, 2025 Earnings Release 2025-08-04 (AFTER CLOSE) |
-13.56%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-6.92%
|
| Feb 04, 2025 Earnings Release 2025-02-04 (BEFORE OPEN) |
-0.50%
|
| Nov 04, 2024 Earnings Release 2024-11-04 (AFTER CLOSE) |
+2.16%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.6%
Bullish Gaps (2)
Bearish Gaps (6)
Neutral / Flat (6)
📖 Intelligence Summary
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗